Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-08-18

FDA Approved: ONDANSETRON — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for ondansetron from Glenmark Pharmaceuticals Inc., USA, for a generic product; this action may involve updated labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)